CHICAGO--(BUSINESS WIRE)--The Canadian Football League (CFL) has expanded its research program with King-Devick Test in association with Mayo Clinic (K-D Test) from a four team pilot program initiated in 2015 to a league wide program (nine teams) in 2016. The announcement was made today by King-Devick Test, Inc. Founder and CEO Steve Devick.
“We work with organizations and athletes of all ages around the world who continue to recognize the value of our test in screening for head trauma,” said Devick. “It’s exciting to add the CFL to our growing list of partners as the CFL continues to lead the way in instituting player safety measures for athletes.”
K-D Test is a quick, accurate and reliable concussion screening tool that only takes two minutes to administer on the sidelines. Athletes read single digit numbers (Rapid Number Naming) displayed on an iPad, Android or Surface tablet following suspected head injury. Results are then compared to a pre-season baseline score. Any worsening of performance in time and/or errors indicates the athlete should be removed-from-play for further evaluation. The tablet-based test can be administered by trained parents, coaches and medical professionals to aid with the detection of any concussion – suspected, unwitnessed and/or unreported.
“Our research last year, conducted in concert with the National Football League, showed promising results and that has led the medical staffs from our clubs to conclude that the K-D Test is a viable tool and worth implementing across the CFL,” said Kevin McDonald, vice-president of football operations and player safety for the CFL.
The implementation of K-D Test is one of several player health and safety initiatives The Canadian Football League (CFL) and Canadian Football League Players’ Association (CFLPA) has instituted for the 2016 season and beyond.
About King-Devick Test Inc.
King-Devick Test is used worldwide as a proven indicator of saccadic eye movements as they relate to reading, using Rapid Number Naming. Elite neurological journals have called the King-Devick Test an "accurate and reliable method for identifying athletes with head trauma." Other studies have proven King-Devick Test to help determine neurological functionality in Parkinson's disease, Multiple Sclerosis, ALS, extreme sleep deprivation, and hypoxia. In January 2015, Mayo Clinic and King-Devick Test announced a licensing agreement for the sideline concussion test. The King-Devick Concussion Screening Test is now recognized as the King-Devick Test in association with Mayo Clinic. For more information, please visit www.kingdevicktest.com.